Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Phase II study of MKC-1 in advanced breast cancer cleared to continue

Jan. 26, 2007

New therapeutic agents for cancer imparted in recent patents

Jan. 26, 2007

MEK inhibitor potentiates dasatinib-induced apoptosis of CML cells

Jan. 26, 2007

Notch signaling disruption sensitizes colon cancer cells to oxaliplatin

Jan. 25, 2007

Clinical update on NV-1020

Jan. 25, 2007

Novel sigma2 receptor ligands may be useful against pancreatic cancer

Jan. 25, 2007

Clinical data on AZD-2171 presented at GI Cancer Symposium

Jan. 25, 2007

GSKbeta/catenin pathway accounted for radiosensitization of pancreatic cancer

Jan. 25, 2007

New phase II trial studies Davanat with 5-FU for advanced biliary cancer

Jan. 25, 2007

Medarex and Compugen collaborate on therapeutic antibody development

Jan. 25, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...